At a glance
- Originator Eli Lilly and Company
- Class Butylamines; Furans; Neuroprotectants
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cerebral ischaemia
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Cerebral ischaemia in United Kingdom (unspecified route)
- 01 Mar 2001 New profile
- 01 Mar 2001 Preclinical development for Cerebral ischaemia in United Kingdom (Unknown route)